Cancer Support Community at Gilda’s Club is hosting an informative and supportive workshop to discuss the biology of cancer.

Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for ...

A form of glioma, a type of brain cancer, tends to progress toward greater malignancy due to an increasing tendency of glioma ...

Some breast cancer types are more likely than others to recur. Researchers have known this for more than a decade. But they have long wondered why. "How did those tumor types arise?" said Christina ...

BARCELONA, Spain--(BUSINESS WIRE)--Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovative and ...

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study. Before the end of the ...

Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers SAN ...

Scientists are exploring whether slowing biological aging could eventually help prevent certain cancers before they develop. One of the biggest mysteries cancer researchers are trying to solve is why ...

A new study led by experts at the University of Nottingham suggests a pet gecko with an unusually high risk of tumors may be ...

June 8 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Monday it will acquire biotech Firefly Bio for $1 ‌billion in cash, as it looks to expand its cancer drug pipeline. Firefly's ...

The Liu Lab investigates cancer as a dynamic system shaped by interactions between tumor cells, their microenvironment, and intrinsic stress-response pathways. Our work focuses on identifying ...

Brandon Capital, Australasia’s leading life sciences venture capital firm, today announces the successful exit of its portfolio company Myricx Bio following its agreement to be acquired by Novartis.